These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 14565062)
1. [Medical termination of pregnancy with mifepristone--initial experience at the Sheba Medical Center]. Machtinger R; Goldenberg M; Soriano D; Zolti M; Atlas M; Seidman DS Harefuah; 2003 Oct; 142(10):666-8, 719. PubMed ID: 14565062 [TBL] [Abstract][Full Text] [Related]
2. Randomised controlled trial comparing the efficacy of same-day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36 to 48 hour protocol. Guest J; Chien PF; Thomson MA; Kosseim ML BJOG; 2007 Feb; 114(2):207-15. PubMed ID: 17305893 [TBL] [Abstract][Full Text] [Related]
3. Acceptability of suction curettage and mifepristone abortion in the United States: a prospective comparison study. Jensen JT; Harvey SM; Beckman LJ Am J Obstet Gynecol; 2000 Jun; 182(6):1292-9. PubMed ID: 10871441 [TBL] [Abstract][Full Text] [Related]
4. Termination of early pregnancy using flexible, low-dose mifepristone-misoprostol regimens. Heikinheimo O; Leminen R; Suhonen S Contraception; 2007 Dec; 76(6):456-60. PubMed ID: 18061704 [TBL] [Abstract][Full Text] [Related]
5. Making unsafe abortion safe: medical method. Pradhan P Nepal Med Coll J; 2004 Dec; 6(2):147-51. PubMed ID: 16295750 [TBL] [Abstract][Full Text] [Related]
6. Mifepristone plus vaginal misoprostol vs vaginal misoprostol alone for medical abortion in gestation 63 days or less in Nepalese women: a quasi-randomized controlled trial. Chawdhary R; Rana A; Pradhan N J Obstet Gynaecol Res; 2009 Feb; 35(1):78-85. PubMed ID: 19215552 [TBL] [Abstract][Full Text] [Related]
7. Introduction of early medical abortion in New Zealand: an audit of the first 67 cases. Shand C; Rose SB; Simmons A; Sparrow MJ Aust N Z J Obstet Gynaecol; 2005 Aug; 45(4):316-20. PubMed ID: 16029300 [TBL] [Abstract][Full Text] [Related]
8. Mifepristone followed in 24 hours to 48 hours by misoprostol for late first-trimester abortion. Bracken H; Ngoc NT; Schaff E; Coyaji K; Ambardekar S; Westheimer E; Winikoff B Obstet Gynecol; 2007 Apr; 109(4):895-901. PubMed ID: 17400851 [TBL] [Abstract][Full Text] [Related]
9. Randomized, double-blind, controlled trial of mifepristone in capsule versus tablet form followed by misoprostol for early medical abortion. Liao AH; Han XJ; Wu SY; Xiao DZh; Xiong CL; Wu XR Eur J Obstet Gynecol Reprod Biol; 2004 Oct; 116(2):211-6. PubMed ID: 15358467 [TBL] [Abstract][Full Text] [Related]
10. A randomized study comparing efficacy and patient satisfaction in medical or surgical treatment of miscarriage. Niinimäki M; Jouppila P; Martikainen H; Talvensaari-Mattila A Fertil Steril; 2006 Aug; 86(2):367-72. PubMed ID: 16764872 [TBL] [Abstract][Full Text] [Related]
11. Consistency of medical abortion efficacy from 5 through 14 weeks' gestation. Garbin O; Vayssiere C; Bettahar-Lebugle K; Nisand I Eur J Obstet Gynecol Reprod Biol; 2006 Nov; 129(1):36-40. PubMed ID: 16325992 [TBL] [Abstract][Full Text] [Related]
12. Medical termination of early pregnancy: the Swedish experience. Bygdeman M; Danielsson KG; Marions L J Am Med Womens Assoc (1972); 2000; 55(3 Suppl):195-6, 204. PubMed ID: 10846338 [TBL] [Abstract][Full Text] [Related]
13. Randomized trial of mifepristone and buccal or vaginal misoprostol for abortion through 56 days of last menstrual period. Middleton T; Schaff E; Fielding SL; Scahill M; Shannon C; Westheimer E; Wilkinson T; Winikoff B Contraception; 2005 Nov; 72(5):328-32. PubMed ID: 16246656 [TBL] [Abstract][Full Text] [Related]
14. [The efficacy and acceptability of mifepristone medical abortion with home administration misoprostol provided by private providers linked with the hospital: a prospective study of 433 patients]. Faucher P; Baunot N; Madelenat P Gynecol Obstet Fertil; 2005 Apr; 33(4):220-7. PubMed ID: 15894206 [TBL] [Abstract][Full Text] [Related]
15. Two mifepristone doses and two intervals of misoprostol administration for termination of early pregnancy: a randomised factorial controlled equivalence trial. von Hertzen H; Piaggio G; Wojdyla D; Marions L; My Huong NT; Tang OS; Fang AH; Wu SC; Kalmar L; Mittal S; Erdenetungalag R; Horga M; Pretnar-Darovec A; Kapamadzija A; Dickson K; Anh ND; Tai NV; Tuyet HT; Peregoudov A; BJOG; 2009 Feb; 116(3):381-9. PubMed ID: 19187370 [TBL] [Abstract][Full Text] [Related]
16. Mifepristone- and misoprostol-induced mid-trimester termination of pregnancy: a review of 272 cases. Rose SB; Shand C; Simmons A Aust N Z J Obstet Gynaecol; 2006 Dec; 46(6):479-85. PubMed ID: 17116051 [TBL] [Abstract][Full Text] [Related]
17. Mifepristone and Misoprostol vs Misoprostol Alone in Second Trimester Termination of Pregnancy. Shah D; Rijal P; Thakur A; Rai R JNMA J Nepal Med Assoc; 2018; 56(213):856-860. PubMed ID: 31065120 [TBL] [Abstract][Full Text] [Related]
18. Induction of second trimester abortion (12-20 weeks) with mifepristone and misoprostol: a review of 386 consecutive cases. Goh SE; Thong KJ Contraception; 2006 May; 73(5):516-9. PubMed ID: 16627037 [TBL] [Abstract][Full Text] [Related]
19. A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation. Hamoda H; Ashok PW; Flett GM; Templeton A BJOG; 2005 Aug; 112(8):1102-8. PubMed ID: 16045525 [TBL] [Abstract][Full Text] [Related]